Detalhe da pesquisa
1.
Strategies to enhance the response of liver cancer to pharmacological treatments.
Am J Physiol Cell Physiol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708523
2.
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
Hepatology
; 78(3): 878-895, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745935
3.
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Hepatology
; 76(5): 1259-1274, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395098
4.
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
Int J Mol Sci
; 24(3)2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768380
5.
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems.
Semin Liver Dis
; 42(1): 87-103, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544160
6.
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.
J Hepatol
; 77(4): 991-1004, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750136
7.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
J Hepatol
; 77(1): 177-190, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217064
8.
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
Hepatology
; 73(1): 186-203, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145077
9.
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Hepatology
; 73(6): 2380-2396, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222246
10.
Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models.
Pharmacol Res
; 177: 106056, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995794
11.
STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
J Hepatol
; 74(6): 1429-1441, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515644
12.
MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
Hepatology
; 72(3): 949-964, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863486
13.
Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite.
Cell Mol Life Sci
; 77(9): 1827-1845, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31372684
14.
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
Br J Cancer
; 123(7): 1047-1059, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694694
15.
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
Hepatology
; 70(4): 1246-1261, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972782
16.
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Hepatology
; 69(4): 1632-1647, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411380
17.
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Hepatology
; 70(2): 547-562, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325540
18.
Role of Genetic Variations in the Hepatic Handling of Drugs.
Int J Mol Sci
; 21(8)2020 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326111
19.
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis.
Int J Mol Sci
; 21(23)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261190
20.
Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events.
J Hepatol
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38810883